東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Effect of circovirus vaccination on ...

Potter, Megan Lynn.

FindBook

Google Book

Amazon

博客來

Effect of circovirus vaccination on immune responses, viral load, and growth performance of pigs under field conditions.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Effect of circovirus vaccination on immune responses, viral load, and growth performance of pigs under field conditions./
作者:	Potter, Megan Lynn.
面頁冊數:	148 p.
附註:	Source: Dissertation Abstracts International, Volume: 72-03, Section: B, page: 1336.
Contained By:	Dissertation Abstracts International72-03B.
標題:	Agriculture, Animal Pathology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3438591
ISBN:	9781124427973

Effect of circovirus vaccination on immune responses, viral load, and growth performance of pigs under field conditions.
Potter, Megan Lynn.

Effect of circovirus vaccination on immune responses, viral load, and growth performance of pigs under field conditions. - 148 p.

Source: Dissertation Abstracts International, Volume: 72-03, Section: B, page: 1336.

Thesis (Ph.D.)--Kansas State University, 2010.

Vaccination against porcine circovirus type 2 (PCV2) has become a standard practice to improve pig mortality and growth rate in PCV2-affected herds. Unfortunately, there has been little field-based research evaluating factors which affect circovirus vaccination. The focus of this research was on potential vaccination-affecting factors such as age, dosing strategy, pig genetic makeup, and interaction with other vaccines. A total of 6,275 pigs were used to determine factors which affect circovirus vaccination and the effects of vaccination on average daily gain (ADG), immune responses, and viral circulation under field conditions. In the first study evaluating circovirus vaccination effects on PCV2 antibody titer, regardless of age and dose administration protocol, pigs vaccinated with a 2-dose circovirus vaccine had increased (P ≤ 0.008) antibody titers compared with non-vaccinates. In a second study, dosing strategy failed (P = 0.31) to affect antibody titers. However, product and time after vaccination did affect ( P = 0.005) antibody titers. In another 130-d study across the nursery and finishing phases, pigs vaccinated with a 2-dose circovirus vaccine had decreased (P < 0.001) serum PCV2 viral load compared with non-vaccinates and ADG of vaccinates was better than non-vaccinates. However, the effect was more pronounced (vaccination-by-genetic interaction, P ≤ 0.05) in Duroc-based compared to Pietrain-based pigs. In a study limited to the nursery phase, vaccination for PCV2 and Mycoplasma hyopneumoniae independently reduced ADG and consumption, but the effect was product-dependent. In a 155-d study across the nursery and finishing phases, vaccination with a 2-dose, 2-vaccine program for PCV2 and Mycoplasma hyopneumoniae decreased (P < 0.001) nursery ADG but tended to increase (P = 0.06) finishing ADG compared to a 1-dose, 2-vaccine program, with no difference (P = 0.66) observed between final pig weights. Finally, circovirus vaccination affected PCV2-circulation in high-health research herds but not in a commercial herd where PCV2 DNA was detected in the environment. These results indicate that finishing performance was improved by a 2-dose circovirus vaccine; however, nursery performance was negatively affected by the same product. Circovirus vaccination responses of growth, viral load, and antibody titer were affected by pig genetic makeup, product, and PCV2-exposure status.

ISBN: 9781124427973Subjects--Topical Terms:

1021764
Agriculture, Animal Pathology.

Effect of circovirus vaccination on immune responses, viral load, and growth performance of pigs under field conditions.
LDR:03852nam 2200397 4500 001 1403552
005 20111118095958.5
008 130515s2010 ||||||||||||||||| ||eng d
020 $a 9781124427973
035 $a (UMI)AAI3438591
035 $a AAI3438591
040 $a UMI $c UMI
100 1 $a Potter, Megan Lynn. $3 1682824
245 1 0 $a Effect of circovirus vaccination on immune responses, viral load, and growth performance of pigs under field conditions.
300 $a 148 p.
500 $a Source: Dissertation Abstracts International, Volume: 72-03, Section: B, page: 1336.
500 $a Adviser: Steve S. Dritz.
502 $a Thesis (Ph.D.)--Kansas State University, 2010.
520 $a Vaccination against porcine circovirus type 2 (PCV2) has become a standard practice to improve pig mortality and growth rate in PCV2-affected herds. Unfortunately, there has been little field-based research evaluating factors which affect circovirus vaccination. The focus of this research was on potential vaccination-affecting factors such as age, dosing strategy, pig genetic makeup, and interaction with other vaccines. A total of 6,275 pigs were used to determine factors which affect circovirus vaccination and the effects of vaccination on average daily gain (ADG), immune responses, and viral circulation under field conditions. In the first study evaluating circovirus vaccination effects on PCV2 antibody titer, regardless of age and dose administration protocol, pigs vaccinated with a 2-dose circovirus vaccine had increased (P ≤ 0.008) antibody titers compared with non-vaccinates. In a second study, dosing strategy failed (P = 0.31) to affect antibody titers. However, product and time after vaccination did affect ( P = 0.005) antibody titers. In another 130-d study across the nursery and finishing phases, pigs vaccinated with a 2-dose circovirus vaccine had decreased (P < 0.001) serum PCV2 viral load compared with non-vaccinates and ADG of vaccinates was better than non-vaccinates. However, the effect was more pronounced (vaccination-by-genetic interaction, P ≤ 0.05) in Duroc-based compared to Pietrain-based pigs. In a study limited to the nursery phase, vaccination for PCV2 and Mycoplasma hyopneumoniae independently reduced ADG and consumption, but the effect was product-dependent. In a 155-d study across the nursery and finishing phases, vaccination with a 2-dose, 2-vaccine program for PCV2 and Mycoplasma hyopneumoniae decreased (P < 0.001) nursery ADG but tended to increase (P = 0.06) finishing ADG compared to a 1-dose, 2-vaccine program, with no difference (P = 0.66) observed between final pig weights. Finally, circovirus vaccination affected PCV2-circulation in high-health research herds but not in a commercial herd where PCV2 DNA was detected in the environment. These results indicate that finishing performance was improved by a 2-dose circovirus vaccine; however, nursery performance was negatively affected by the same product. Circovirus vaccination responses of growth, viral load, and antibody titer were affected by pig genetic makeup, product, and PCV2-exposure status.
590 $a School code: 0100.
650 4 $a Agriculture, Animal Pathology. $3 1021764
650 4 $a Biology, Veterinary Science. $3 1021733
650 4 $a Health Sciences, Immunology. $3 1017716
690 $a 0476
690 $a 0778
690 $a 0982
710 2 $a Kansas State University. $b Department of Diagnostic Medicine/Pathobiology. $3 1682825
773 0 $t Dissertation Abstracts International $g 72-03B.
790 1 0 $a Dritz, Steve S., $e advisor
790 1 0 $a Tokach, Mike D. $e committee member
790 1 0 $a Nelssen, Jim L. $e committee member
790 1 0 $a Goodband, Robert D. $e committee member
790 1 0 $a DeRouchey, Joel M. $e committee member
790 1 0 $a Renter, Dave G. $e committee member
790 1 0 $a Hesse, Richard A. $e committee member
790 1 0 $a Rowland, Raymond RR $e committee member
790 1 0 $a Henry, Steven C. $e committee member
790 1 0 $a Tokach, Lisa M. $e committee member
790 $a 0100
791 $a Ph.D.
792 $a 2010
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3438591